Clinical trial
Cisplatin, Pemetrexed Disodium, and Radiation Therapy Followed by Docetaxel in…
NCT00301808 · Barbara Ann Karmanos Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00301808 |
|---|---|
| Title | Cisplatin, Pemetrexed Disodium, and Radiation Therapy Followed by Docetaxel in Treating Patients With Stage III Non-Small Cell Lung Cancer |
| Official title | Phase II Study of Concurrent Cisplatin/Pemetrexed and RT Followed by Docetaxel in Stage III NSCLC (Non Small Cell Lung Cancer) |
| Lead sponsor | Barbara Ann Karmanos Cancer Institute, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug, Radiation |
| Interventions | Cisplatin, Docetaxel, Pemetrexed disodium, Radiation therapy |
| Enrollment | 29 |
| Start date | Nov 1, 2005 |
| Primary completion | Sep 1, 2012 |
| Completion | Oct 1, 2012 |
| First posted | Mar 13, 2006 |
| Last update posted | May 6, 2023 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: